Loader

Pathways

PathWhiz ID Pathway Meta Data

PW002515

Pw002515 View Pathway
protein

Stress-Activated Signalling Pathways: Low Osmolarity

Saccharomyces cerevisiae
Stress-activated protein kinase pathways in Saccharomyces. The HOG1 MAPK pathway is controlled by two separate osmosensors, SLN1 and SHO1. Sln1 is activated in low osmolarity, thus repressing Ssk1 by phosphorylating it. Ssk1 is in charge of activating Ssk2/22 which in turn activates Pbs2 and in turn activates Hog1. SHO1 is activated during high osmolarity, resulting in Ste11 being activated, which in turn activates Pbs2 and activates Hog1. Ptp2 and Ptp3 negatively regulates Hog1.

PW012843

Pw012843 View Pathway
signaling

Stress-activated signalling pathways: pheromone stress test 1

Saccharomyces cerevisiae

PW003483

Pw003483 View Pathway
signaling

Stress-activated signalling pathways: starvation test 1

Saccharomyces cerevisiae

PW000564

Pw000564 View Pathway
physiological

Striated Muscle Contraction

Homo sapiens
Tubular striated muscle cells (i.e. skeletal and cardiac myocytes) are composed of bundles of rod-like myofibrils. Each individual myofibril consists of many repeating units called sarcomeres. These functional units, in turn, are composed of many alternating actin and mysoin protein filaments that produce muscle contraction. The muscle contraction process is initiated when the muscle cell is depolarized enough for an action potential to occur. When acetylcholine is released from the motor neuron axon terminals that are adjacent to the muscle cells, it binds to receptors on the sarcolemma (muscle cell membrane), causing nicotinic acetylcholine receptors to be activated and the sodium/potassium channels to be opened. The fast influx of sodium and slow efflux of potassium through the channel causes depolarization. The resulting action potential that is generated travels along the sarcolemma and down the T-tubule, activating the L-type voltage-dependent calcium channels on the sarcolemma and ryanodine receptors on the sarcoplasmic reticulum. When these are activated, it triggers the release of calcium ions from the sarcoplasmic reticulum into the cytosol. From there, the calcium ions bind to the protein troponin which displaces the tropomysoin filaments from the binding sites on the actin filaments. This allows for myosin filaments to be able to bind to the actin. According to the Sliding Filament Theory, the myosin heads that have an ADP and phosphate attached binds to the actin, forming a cross-bridge. Once attached, the myosin performs a powerstroke which slides the actin filaments together. The ATP and phosphate are dislodged during this process. However, ATP now binds to the myosin head, which causes the myosin to detach from the actin. The cycle repeats once the attached ATP dissociates into ADP and phosphate, and the myosin performs another powerstroke, bringing the actin filaments even closer together. Numerous actin filaments being pulled together simultaneously across many muscles cells triggers muscle contraction.

PW147060

Pw147060 View Pathway
metabolic

Strontium chloride Drug Metabolism Pathway

Homo sapiens

PW146174

Pw146174 View Pathway
drug action

Strontium chloride Sr-89 Drug Metabolism Action Pathway

Homo sapiens

PW132292

Pw132292 View Pathway
metabolic

Strontium ranelate Drug Metabolism

Homo sapiens
Strontium ranelate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Strontium ranelate passes through the liver and is then excreted from the body mainly through the kidney.

PW146058

Pw146058 View Pathway
drug action

Strontium ranelate Drug Metabolism Action Pathway

Homo sapiens

PW144683

Pw144683 View Pathway
drug action

Succimer Drug Metabolism Action Pathway

Homo sapiens

PW126414

Pw126414 View Pathway
metabolic

Succinate Immunometabolism Pathway

Homo sapiens